Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-15

Clinical Trial Update: To Compare the Efficacy and Safety of Oral SHR 7280 Tablets With Ganirelix Acetate Injection in Infertile Female Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial completed comparing the efficacy and safety of SHR 7280 tablets versus ganirelix acetate injections to suppress premature LH surge during controll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ganirelix acetate (ganirelix acetate)
  • SHR 7280

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Infertile Female Subjects Undergoing Controlled Ovarian Hyperstimulation to Suppress Premature LH Surge and Prevent Early Ovulation | Phase 3 | Status: COMPLETED